Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.6203 | 1 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0006 | 0.0244 | 0.0026 |
Leishmania major | cytidine deaminase-like protein | 0.0121 | 1 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0006 | 0.0244 | 0.0026 |
Trypanosoma cruzi | cytidine deaminase-like protein, putative | 0.0121 | 1 | 1 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0006 | 0.0244 | 0.0026 |
Entamoeba histolytica | cytidine deaminase, putative | 0.0121 | 1 | 1 |
Mycobacterium tuberculosis | Probable cytidine deaminase Cdd (cytidine aminohydrolase) (cytidine nucleoside deaminase) | 0.0121 | 1 | 1 |
Onchocerca volvulus | 0.0006 | 0.0218 | 0.0218 | |
Giardia lamblia | Cytidine deaminase | 0.0121 | 1 | 1 |
Echinococcus multilocularis | cytidine and deoxycytidylate deaminase | 0.0006 | 0.0218 | 0.0218 |
Echinococcus multilocularis | deoxycytidylate deaminase | 0.0006 | 0.0218 | 0.0218 |
Chlamydia trachomatis | bifunctional diaminohydroxyphosphoribosylaminopyrimidine deaminase/5-amino-6-(5-phosphoribosylamino) uracil reductase | 0.0006 | 0.0218 | 0.5 |
Schistosoma mansoni | cytidine/deoxycytidylate deaminase-related | 0.0006 | 0.0218 | 0.0352 |
Onchocerca volvulus | Putative deoxycytidylate deaminase | 0.0006 | 0.0218 | 0.0218 |
Loa Loa (eye worm) | hypothetical protein | 0.0006 | 0.0218 | 0.0352 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.6203 | 1 |
Echinococcus granulosus | cytidine deaminase | 0.0121 | 1 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.6203 | 0.6203 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0006 | 0.0244 | 1 |
Toxoplasma gondii | cytidine and deoxycytidylate deaminase zinc-binding region domain-containing protein | 0.0121 | 1 | 1 |
Echinococcus multilocularis | cytidine deaminase | 0.0121 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0006 | 0.0244 | 0.0394 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0006 | 0.0244 | 0.0026 |
Schistosoma mansoni | deoxycytidylate deaminase | 0.0006 | 0.0218 | 0.0352 |
Trypanosoma cruzi | cytidine deaminase-like protein | 0.0121 | 1 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0006 | 0.0244 | 0.0244 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.6203 | 1 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0006 | 0.0244 | 0.0244 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.6203 | 0.6203 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0006 | 0.0244 | 0.0026 |
Echinococcus granulosus | cytidine and deoxycytidylate deaminase | 0.0006 | 0.0218 | 0.0218 |
Echinococcus multilocularis | tRNA specific adenosine deaminase 2 | 0.0006 | 0.0218 | 0.0218 |
Loa Loa (eye worm) | tRNA-specific adenosine deaminase 2 | 0.0006 | 0.0218 | 0.0352 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0006 | 0.0244 | 0.0026 |
Trichomonas vaginalis | cytidine deaminase, putative | 0.0121 | 1 | 1 |
Schistosoma mansoni | cytidine/deoxycytidylate deaminase-related | 0.0006 | 0.0218 | 0.0352 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0006 | 0.0244 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.6203 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.6203 | 1 |
Brugia malayi | RNA binding protein | 0.0076 | 0.6203 | 0.6203 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.6203 | 0.6203 |
Schistosoma mansoni | dCTP deaminase | 0.0006 | 0.0218 | 0.0352 |
Loa Loa (eye worm) | dCMP deaminase | 0.0006 | 0.0218 | 0.0352 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0006 | 0.0244 | 0.0026 |
Onchocerca volvulus | 0.0121 | 1 | 1 | |
Echinococcus granulosus | tRNA specific adenosine deaminase 2 | 0.0006 | 0.0218 | 0.0218 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0006 | 0.0244 | 0.0026 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0006 | 0.0244 | 0.0244 |
Mycobacterium ulcerans | cytidine deaminase | 0.0121 | 1 | 1 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0006 | 0.0244 | 0.0394 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.6203 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.0006 | 0.0244 | 0.0026 |
Brugia malayi | Cytidine and deoxycytidylate deaminase zinc-binding region family protein | 0.0006 | 0.0218 | 0.0218 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0006 | 0.0244 | 0.0026 |
Echinococcus granulosus | deoxycytidylate deaminase | 0.0006 | 0.0218 | 0.0218 |
Brugia malayi | dCMP deaminase | 0.0006 | 0.0218 | 0.0218 |
Trichomonas vaginalis | cytidine deaminase, putative | 0.0121 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0006 | 0.0244 | 0.0394 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0006 | 0.0244 | 0.0026 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.6203 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0006 | 0.0244 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.6203 | 1 |
Mycobacterium leprae | PROBABLE CYTIDINE DEAMINASE CDD (CYTIDINE AMINOHYDROLASE) (CYTIDINE NUCLEOSIDE DEAMINASE) | 0.0121 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.6203 | 0.6203 |
Onchocerca volvulus | 0.0121 | 1 | 1 | |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0006 | 0.0244 | 1 |
Trypanosoma brucei | cytidine deaminase | 0.0121 | 1 | 1 |
Brugia malayi | tRNA-specific adenosine deaminase 2 | 0.0006 | 0.0218 | 0.0218 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.